MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
Open Access
- 22 August 2014
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (19) , 8893-8905
Abstract
MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cellsKeywords
This publication has 44 references indexed in Scilit:
- RAS oncogenes: weaving a tumorigenic webNature Reviews Cancer, 2011
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and ActivityCancer Cell, 2011
- The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?EMBO Reports, 2010
- A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung CarcinomaCancer Cell, 2010
- Mucins in cancer: function, prognosis and therapyNature Reviews Cancer, 2009
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell SurvivalCancer Cell, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersNature Medicine, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008